Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 12:2022:8336561.
doi: 10.1155/2022/8336561. eCollection 2022.

Managing Chronic Neuropathic Pain: Recent Advances and New Challenges

Affiliations
Review

Managing Chronic Neuropathic Pain: Recent Advances and New Challenges

Namrata Hange et al. Neurol Res Int. .

Abstract

Aim: Neuropathic pain affects 7-10% of the population, with most of the patients receiving inadequate and incomplete treatment. Owing to the high financial burden and the poor quality of life of the patients and their caretakers, there is a dire need to address the challenges in diagnosing and treating chronic neuropathic pain.

Methods: This literature review was conducted to review novel treatments and related challenges through a systematic search from sources such as PubMed, Google Scholar with the combination of MESH words such as neuropathic pain, management of neuropathic pain. Articles from non-English literature, reports without human subjects, animal studies, and abstracts/posters were excluded. However, human studies and studies published in English were included.

Result: This review article discusses novel treatment modalities while acknowledging the challenges medical workers face while encountering neuropathic pain. Despite the recent advances in diagnosis and treatment modalities, several challenges still exist. Hence, there is still a need to explore the various treatment modalities, emphasizing the cause and underlying pathophysiology of neuropathic pain.

Conclusion: We recommend integrated multimodal treatment with the current treatment facility, including various medical disciplines. However, a personalized approach would work the best depending on the 'patient's medical history. Therefore, this article recommends an integrated, cause-specific, cost-effective approach to address this problem of chronic neuropathic pain.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The comprehensive algorithm for the management of chronic neuropathic pain published in 2019.
Figure 2
Figure 2
Consensus statement for the management of chronic neuropathic pain by the Canadian Pain Society.

References

    1. Van Hecke O., Austin S. K., Khan R. A., Smith B. H., Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain . 2014;155(4):654–662. doi: 10.1016/J.PAIN.2013.11.013. - DOI - PubMed
    1. Colloca L., Ludman T., Bouhassira D., et al. Neuropathic pain. Nature Reviews Disease Primers . 2017;3(1):p. 17002. doi: 10.1038/NRDP.2017.2. - DOI - PMC - PubMed
    1. Miller E., Morel A., Redlicka J., Miller I., Saluk J. Pharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis. Current Neuropharmacology . 2018;16(4):475–483. doi: 10.2174/1570159X15666171109132650. - DOI - PMC - PubMed
    1. Dworkin R. H., O’Connor A. B., Audette J., et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings . 2010;85(3):S3–S14. doi: 10.4065/MCP.2009.0649. - DOI - PMC - PubMed
    1. O’Connor A. B. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. PharmacoEconomics . 2009;27(2):95–112. doi: 10.2165/00019053-200927020-00002. - DOI - PubMed

LinkOut - more resources